文献速递艾滋病与性传播感染医院感染防控

使用炔雌醇/依托孕烯阴道环改变HIV感染女性的阴道微生物群落

Use of an Ethinyl Estradiol/Etonogestrel Vaginal Ring Alters Vaginal Microbial Communities in Women With HIV.
PubMed 文献 · J Infect Dis · 2025-01-01

本研究对74名接受依托孕烯/炔雌醇阴道环的HIV感染女性进行16S RNA测序等分析,发现阴道环治疗与乳杆菌优势群落状态类型概率增加相关(OR=1.61,P=.04),且HIV-1阴道排毒在卷曲乳杆菌优势者中较少见(P=.04),混合厌氧群落以方案特异性方式调节炔雌醇浓度。

要点

  • 阴道环治疗期间乳杆菌优势群落状态类型概率增加(OR=1.61,P=.04)。
  • 卷曲乳杆菌优势微生物组者HIV-1阴道排毒较少见(P=.04)。
  • 混合厌氧阴道群落以方案特异性方式调节炔雌醇浓度。

核心结论

  • 联合依托孕烯/炔雌醇阴道环治疗与HIV感染女性乳杆菌优势阴道微生物群落增加相关,可能对细菌性阴道病患者有益。
  • 炔雌醇水平受阴道微生物群改变。

研究设计与样本

  • 对74名接受依托孕烯/炔雌醇阴道环的HIV感染女性进行研究,其中未接受抗逆转录病毒治疗者25名、基于依非韦伦治疗者25名、基于阿扎那韦治疗者24名。
  • 通过每周阴道拭子16S RNA测序评估阴道微生物,质谱法测阴道短链脂肪酸,核酸扩增法测阴道抽吸液HIV-1排毒,Nugent评分评估细菌性阴道病。

主要发现

  • 基线时64名亚研究合格参与者微生物群落分类为卷曲乳杆菌优势(n=8)、加氏乳杆菌优势(n=2)、惰性乳杆菌优势(n=17)或混合厌氧群落(n=37)。
  • 阴道环治疗期间乳杆菌优势群落状态类型概率增加(OR=1.61,P=.04)。
  • 阴道群落状态类型与Nugent评分相关;细菌性阴道病相关细菌与显著更高的Nugent评分相关,惰性乳杆菌与更低的Nugent评分相关(所有校正P<.1)。
  • 乳酸水平与乳杆菌属相对丰度相关(r2=0.574;P<.001)。
  • 卷曲乳杆菌优势微生物组女性中HIV-1阴道排毒较少见(P=.04)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Human immunodeficiency virus 1 (HIV-1) antiretroviral therapy (ART) alters hormonal contraceptive levels delivered via intravaginal ring (IVR) in a regimen-specific manner. We explored the role of the IVR on vaginal microbial communities, vaginal short chain fatty acids (SCFAs), vaginal HIV shedding, and the effect of vaginal microbes on hormone concentrations in cisgender women with HIV (WWH). METHODS: Vaginal microbes were assessed by 16S RNA sequencing of weekly vaginal swabs, vaginal SCFA by mass spectrometry, HIV-1 shedding by nucleic acid amplification on vaginal aspirates, and bacterial vaginosis by Nugent scoring from 74 participants receiving an etonogestrel/ethinyl estradiol (ENG/EE) intravaginal ring while on no ART (n = 25), efavirenz-based ART (n = 25), or atazanavir-based ART (n = 24). RESULTS: At baseline, microbial communities of the 64 substudy eligible participants robustly classified as Lactobacillus crispatus-dominant (n = 8), Lactobacillus gasseri-dominant (n = 2), Lactobacillus iners-dominant (n = 17), or mixed anaerobic communities (n = 37). During IVR therapy, there was an increased probability of Lactobacillus-dominant community state types (CSTs) (odds ratio = 1.61, P = .04). Vaginal CSTs were associated with Nugent scores. Bacterial vaginosis-associated bacteria were associated with significantly higher and L. iners with lower Nugent scores (all P adjusted <.1). Lactic acid levels were correlated with the relative abundance of Lactobacillus species (r2 = 0.574; P < .001). Vaginal shedding of HIV-1 was less common in women with L. crispatus-dominant microbiomes (P = .04). Mixed anaerobic vaginal communities modulated EE concentrations in a regimen-specific manner. CONCLUSIONS: Combined ENG/EE IVR therapy was associated with an increase in Lactobacillus-dominant vaginal microbial communities in WWH and may benefit those with bacterial vaginosis. EE levels were altered by the vaginal microbiota.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Tobin NH, Brooker SL, Li F, et al. Use of an Ethinyl Estradiol/Etonogestrel Vaginal Ring Alters Vaginal Microbial Communities in Women With HIV. J Infect Dis. 2025. PMID: 39479902. doi:10.1093/infdis/jiae524

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。